Crovalimab Uses, Dosage, Side Effects and more
Crovalimab is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria).
| Trade Name | Crovalimab |
| Generic | Crovalimab |
| Crovalimab Other Names | Complement c5 inhibitory humanized recycling monoclonal antibody (rg-6107 ), Crovalimab, Immunoglobulin g1, anti-(human complement c5)(humanized ro7112689 heavy chain), disulfide with humanized ro7112689 light chain, dimer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
